Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus

Conditions:   HF - Heart Failure;   Diabetes Mellitus Intervention:   Drug: Bumetanide 0.5 mg, dapaglifozin 5 mg, eplerenone 25 mg Sponsor:   Northwestern University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials